Delivery Order SPE2DB20D1102-SPE2DB25FC6DU
Award Date
4/23/25
Potential Completion Date
4/24/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of hydroxyzine 50 mg/ml vials, with a total ceiling value of $1,205.50 and an ultimate completion date of July 3, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hydroxyzine 50 mg/mL vials, a medication used for various medical conditions. The contract has a firm fixed price of $2,782.33 and a performance period through June 30, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999.00...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,812.72, is for the delivery of Hydroxyzine 50 mg/ml vials. The contract has a firm fixed-price pricing type and an ultimate completion date of July 2, 2025. This appears to be a non-set-aside contract, meaning it was open to full and open competition. Amerisourcebergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,777.13, is for the delivery of hydroxyzine 50 mg/mL vials. This is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA for providing a comprehensive range of pharmaceutical products and medical supplies...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4563094112 - Hydroxyzine 50 mg/mL vials, with a ceiling value of $3,023.35 and a completion date of December 14, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,607.18 firm-fixed-price delivery order is for the supply of 4566448421 - Hydroxyzine 50 mg/ml vial. The award has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of hydroxyzine 50 mg/ml vials, a specialty pharmaceutical product, with a potential value of $1,410.66 and a completion date of February 2, 2024. This award is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HYDROXYZINE 50 MG/ML VIALML, a pharmaceutical product, with a ceiling value of $6,645.98 and a period of performance ending on July 7, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,099.36 fixed-price contract is for the delivery of Hydroxyzine 50 mg/ml vials, a medication used to treat anxiety and tension. The contract has a performance period through June 24, 2025 and is not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,198.37 Firm Fixed Price Delivery Order contract provides for the procurement of hydroxyzine 50 mg/ml vials. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...